Three decades after the unobtrusive debut of the peroxisome as a distinct subcellular organelle, biologists are paying attention to the special bag of tricks eukaryotic cells use to entice peroxisomal proteins from their site of synthesis in the cytosol to the peroxisome. In this minireview, we highlight some of the recent findings that have emerged, emphasize their significance, and contrast them with aspects of protein import into other subcellular destinations.
Peroxisomal
Targeting Signals -The Beginning, the Middle, and the End Genetic and biochemical evidence has underscored the conservation of peroxisomal targeting signals (PTSs) from yeast to humans and led to the elucidation of at least two pathways for the transport of proteins to the peroxisome matrix (lumen). Each of these pathways is dependent on the molecular recognition of a specific PTS by its cognate receptor, which then hands off the protein to a putative translocation machinery housed in the peroxisome membrane. PTSl is a conserved C-terminal tripeptide (SKL or a variant) that constitutes the major targeting signal for proteins destined for the peroxisome matrix. In contrast, PTS2 is a conserved N-terminal nonapeptide (R/K)(L/V/I) (X)5(H/Q)(L/A) used by a smaller subset of peroxisomal matrix proteins. Other internally located PTSs have been described but remain poorly characterized (Purdue and Lazarow, 1994) .
Peroxisomal membrane proteins do not possess either PTSl or PTS2 sequences but are endowed instead with PTSs that have been defined only as fairly large internal segments of peroxisomal membrane proteins (Purdue and Lazarow, 1994) .
Despite the fact that all these PTSs are known to be necessary and sufficient for targeting to peroxisomes, a novel twist (addressed later) is the recent discovery that polypeptide chains devoid of a PTS can hitch a ride into peroxisomes by association with subunits that contain a PTS (Glover et al., 1994; McNew and Goodman, 1994) . Omnipresent PTS Receptors Yeast and human cells selectively deficient in the PTS1 or PTS2 import pathway (or both) have been instrumental in the identification of PTS receptors. The earliest mutant discovered to be selectively compromised in the PTSl pathway alone was the pas8 mutant of Pichia pastoris. The protein, Pas8p, is tightly associated with the cytosolic face of the peroxisome membrane and is the PTSl receptor (PTSl R) (Terlecky et al., 1995;  Figure 1 ).
Minireview Surprisingly, homologs of Pas8p that complement mutants with pasb-like phenotypes in other yeasts exhibit different subcellular locations ranging from cytosolic (e.g., PaslOp of Saccharomyces cerevisiae [van der Leij et al., 19931; Per3p of Hansenula polymorpha [van der Klei et al., 19953) to intraperoxisomal (Pay32p of Yarrowia lipolytica [Szilard et al., 1995) ). Likewise, the human PTSlR has been reported by some groups to be primarily cytosolic and partly peroxisomal (Dodt et al., 1995; Wiemer et al., 1995) and by others to be exclusively peroxisomal (Fransen et al., 1995) .
Equally puzzling results have emerged from studies with the PTSP receptor (PTS2R). Complementation of the S. cerevisiae pas7 mutant, deficient only in the PTS2 import pathway, led to the isolation of thePAS7gene, thought to encode PTS2R. Marzioch et al. (1994) , who reported Pas7p to be primarily cytosolic and only partially associated with peroxisomes, proposed a model in which PTS2R shuttles between the cytosol and the peroxisome membrane. In contrast, Zhang and Lazarow (1995) reported Pas7p to be intraperoxisomal and suggested instead that it might actasachaperone,andnotasareceptor, in pulling PTSBcontaining proteins into the peroxisome. While the resolution of this discrepancy may stem eventually from the details of the different epitope-tagged molecules localized or, alternatively, from the levels of expression used, one is hard pressed to reconcile how the same protein could be in such different locations unless these locations are linked to the biological functions of the protein.
Shuttling
Receptors or Experimental Illusions? If the multiple subcellular locations of PTSl R and PTS2R are real and, perhaps, dependent on the physiological status of a cell, several critical issues must be addressed. Do all subcellular forms of the receptors bind PTSs? How are the receptors distributed quantitatively in each location, and which of these pools is physiologically related to protein import? Do the receptors shuttle between the cytosol and the peroxisome membrane, as shown in Figure 2, and are there any circumstances under which the failure to release the receptors from the peroxisome membrane results in transport of the receptor to the matrix in association with their PT.5containing ligands, as alluded to earlier (see box in Figure 2 )? Alternatively, is there a specific signal that targets the receptors to the matrix? Are the receptors that are found in the matrix actively engaged in protein import, or are they deadend molecules? Can receptors shuttle back out of the peroxisome to facilitate multiple rounds of import? If any of these unorthodox mechanisms is correct, peroxisomal protein import would be very different from protein import across the endoplasmic reticulum, mitochondrial membranes, or chloroplast membranes.
PTS Receptors and Human Disease
The remarkable conservation of PTSs and PTSl R homologs in different yeasts, as well as the similar phenotypes of the yeast mutants defective in the PTSl pathway alone, suggested that a protein homologous to P. pastoris Pas8p might be conserved in humans. An important impetus to the search for a human homolog was the clinical documentation over the last 30 years of a series of extremely debilitating (and invariably fatal) human peroxisomal disorders. These disorders fall into three groups: A, 6, and C. In group C, the enzymatic activity or the subcellular localization of asingle peroxisomal protein is compromised. Disorders of groups A and B are more interesting because, although a single gene is affected in each patient, multiple peroxisomal proteins are often mislocalized to the cytosol. Cells from these patients have peroxisome "ghosts" missing a few, or many, of the contents of the peroxisome matrix. That these diseases exhibit deficiencies in the PTSl or PTS2 import pathways is well documented (Motley et al., 1994) . The cytosolic localization and peroxisome membrane association of PTSl R and PTSZR could be explained by shuttling of the receptors between the cytosol and the peroxisome membrane during rounds of transport of PTScontaining proteins from the cytosol to the peroxisome-associated translocation machinery. In this model, hypothetical proteins (hatched) function either as "gatekeepers" to obstruct the entry of PTS receptors into the matrix in association with their PTS-containing ligands or as "recyclers" to facilitate the return of the receptors to the cytosol. Under certain physiological or artificially created conditions, the absence of such proteins might result in the entry of the receptors into the matrix (see stippled box), explaining their matrix localization.
In such a hypothetical model, a key question is whether mechanisms exist for the export of the receptors from the matrix back to the cytosol. (Dodt et al., 1995) . Furthermore, the human PTSlR can complement the protein import defect in these cells (Dodt et al., 1995; Wiemer et al., 1995 polypepticles oligomerizing with peroxisomal matrix polypeptides to gain access to the peroxisome. This form of targeting in tram remains hypothetical and is different from what one has come to expect from studies of other organelles. Furthermore, it raises a caveat for future targeting studies. Domains required for multimerization with proteins containing PTS motifs could readily be confused with the PTSs themselves. The identification of receptor molecules that recognize and bind true PTSs should lead to discrimination between these two alternatives. A picture of how proteins are imported into peroxisomes is starting to emerge. What is readily apparent is that cells have developed unique solutions to the problem of moving proteins from their initial site of synthesis on cytoplasmic polysomes to their final destination inside the peroxisome. These solutions will undoubtedly lead to a better understanding of the evolution of this organelle.
